Literature DB >> 12738807

Hydrogen sulfide induces serum-independent cell cycle entry in nontransformed rat intestinal epithelial cells.

Bart Deplancke1, H Rex Gaskins.   

Abstract

Hydrogen sulfide (H2S), produced by commensal sulfate-reducing bacteria, is an environmental insult that potentially contributes to chronic intestinal epithelial disorders. We tested the hypothesis that exposure of nontransformed intestinal epithelial cells (IEC-18) to the reducing agent sodium hydrogen sulfide (NaHS) activates molecular pathways that underlie epithelial hyperplasia, a phenotype common to both ulcerative colitis (UC) and colorectal cancer. Exposure of IEC-18 cells to NaHS rapidly increased the NADPH/NADP ratio, reduced the intracellular redox environment, and inhibited mitochondrial respiratory activity. The addition of 0.2-5 mM NaHS for 4 h increased the IEC-18 proliferative cell fraction (P<0.05), as evidenced by analysis of the cell cycle and proliferating cell nuclear antigen expression, while apoptosis occurred only at the highest concentration of NaHS. Thirty minutes of NaHS exposure increased (P<0.05) c-Jun mRNA concentrations, consistent with the observed activation of mitogen activated protein kinases (MAPK). Microarray analysis confirmed an increase (P<0.05) in MAPK-mediated proliferative activity, likely reflecting the reduced redox environment of NaHS-treated cells. These data identify functional pathways by which H2S may initiate epithelial dysregulation and thereby contribute to UC or colorectal cancer. Thus, it becomes crucial to understand how genetic background may affect epithelial responsiveness to this bacterial-derived environmental insult.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12738807     DOI: 10.1096/fj.02-0883fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  44 in total

Review 1.  Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects.

Authors:  Katalin Módis; Eelke M Bos; Enrico Calzia; Harry van Goor; Ciro Coletta; Andreas Papapetropoulos; Mark R Hellmich; Peter Radermacher; Frédéric Bouillaud; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

2.  Race-dependent association of sulfidogenic bacteria with colorectal cancer.

Authors:  Cemal Yazici; Patricia G Wolf; Hajwa Kim; Tzu-Wen L Cross; Karin Vermillion; Timothy Carroll; Gaius J Augustus; Ece Mutlu; Lisa Tussing-Humphreys; Carol Braunschweig; Rosa M Xicola; Barbara Jung; Xavier Llor; Nathan A Ellis; H Rex Gaskins
Journal:  Gut       Date:  2017-02-02       Impact factor: 23.059

3.  A Review of Hydrogen Sulfide Synthesis, Metabolism, and Measurement: Is Modulation of Hydrogen Sulfide a Novel Therapeutic for Cancer?

Authors:  Xu Cao; Lei Ding; Zhi-Zhong Xie; Yong Yang; Matthew Whiteman; Philip K Moore; Jin-Song Bian
Journal:  Antioxid Redox Signal       Date:  2018-06-29       Impact factor: 8.401

Review 4.  The gastrointestinal microbiota and colorectal cancer.

Authors:  Temitope O Keku; Santosh Dulal; April Deveaux; Biljana Jovov; Xuesong Han
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-24       Impact factor: 4.052

5.  Inhibition of endogenous hydrogen sulfide production in clear-cell renal cell carcinoma cell lines and xenografts restricts their growth, survival and angiogenic potential.

Authors:  Eric Sonke; Megan Verrydt; Carl O Postenka; Siddika Pardhan; Chantalle J Willie; Clarisse R Mazzola; Matthew D Hammers; Michael D Pluth; Ian Lobb; Nicholas E Power; Ann F Chambers; Hon S Leong; Alp Sener
Journal:  Nitric Oxide       Date:  2015-06-09       Impact factor: 4.427

6.  Hydrogen sulfide protects colon cancer cells from chemopreventative agent beta-phenylethyl isothiocyanate induced apoptosis.

Authors:  Peter Rose; Philip-K Moore; Shen-Han Ming; Ong-Choon Nam; Jeffrey-S Armstrong; Matt Whiteman
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

Review 7.  Hydrogen sulfide signaling in the gastrointestinal tract.

Authors:  David R Linden
Journal:  Antioxid Redox Signal       Date:  2013-05-19       Impact factor: 8.401

8.  Hydrogen Sulfide and its Interaction with Other Players in Inflammation.

Authors:  Sumeet Manandhar; Priyanka Sinha; Grace Ejiwale; Madhav Bhatia
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  The endogenous hydrogen sulfide producing enzyme cystathionine-beta synthase contributes to visceral hypersensitivity in a rat model of irritable bowel syndrome.

Authors:  Guang-Yin Xu; John H Winston; Mohan Shenoy; Shufang Zhou; Jiande D Z Chen; Pankaj J Pasricha
Journal:  Mol Pain       Date:  2009-08-06       Impact factor: 3.395

Review 10.  Physiological and pharmacological features of the novel gasotransmitter: hydrogen sulfide.

Authors:  Daniele Mancardi; Claudia Penna; Annalisa Merlino; Piero Del Soldato; David A Wink; Pasquale Pagliaro
Journal:  Biochim Biophys Acta       Date:  2009-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.